Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate
DoD funding aims to advance F. tularensis biodefense vaccine candidate to IND submission Appili Therapeutics Inc. announced this week that ...
Tag: F. tularensis
2021 BAA for Development of Medical Countermeasures for Biological Threats
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is soliciting research ...
Validated Methods for Removing Select Agent Samples from BSL-3 Labs
The Federal Select Agent Program dictates that all research entities in the United States must rigorously assess laboratory protocols to ...
Fresh Approach to an Old Problem Yields Clues to Tularemia Virulence
Francisella tularensis, also called rabbit fever, is an equal opportunity pathogen: it causes the disease tularemia in humans, rabbits and ...
Henry Eigelsbach, Microbiologist Known for Tularemia Research, Dies at 100
Renowned microbiologist Henry “Hank” Eigelsbach died of natural causes on December 6, 2019 at the age of 100. The former ...
Naval Research Laboratory Seeks to Advance Field Diagnostics of Infectious Agents
The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable ...
BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures ...
Achaogen Gets Federal Funding for Biowarfare Agent Therapeutic Development
The U.S. federal government is backing an antibiotic that not only holds potential as a treatment for infections from certain ...
Distinguishing Virulent from Harmless Bacteria to Improve Biosurveillance
At left, principal investigator Jean Challacombe, assisted by Cheryl Gleasner, work on sequencing the Francisella genomes at Los Alamos. The ...
What Makes Francisella So Dangerous?
A negative stain electron micrograph of a dense culture of Francisella bacteria.Credit: Alexandra Walls and Aria Eshraghi Scientists are gaining ...
New Mutations Identified in Antibiotic-Resistant Bioterrorism Agent
LLNL biologist Crystal Jaing with the structural model of topoisomerase enzyme FTL_1547. A mutation position is colored in red. Photo by ...
Liposomal Ciprofloxacin as Broad-Spectrum Bioterrorism Countermeasures
The U.K. Defence Science and Technology Laboratory (Dstl) has received funding of up to $6.9 million from the U.S. Defense ...
GAO Recommendations on Select Agent Program Improvements
The total number of incidents involving incomplete inactivation—a process to destroy the hazardous effects of pathogens while retaining characteristics for ...
DoD CBRN Medical Countermeasure Consortium
Military program managers briefed biopharmaceutical industry and research organization representatives during a Nov. 2 Industry Day, part of an initiative ...
Positive Results for Arno Therapeutics’ Broad Spectrum Antimicrobial
Biopharmaceutical company Arno Therapeutics, Inc. has announced promising data demonstrating novel activity of AR-12 as a broad-spectrum, anti-microbial drug. Results ...
BAA – Medical Countermeasures for Priority Pathogens
The National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) to support development ...
Key Molecules Identified For Battling Deadly Tularemia
Research led by scientists at St. Jude Children's Research Hospital has identified key molecules that trigger the immune system to ...
NIAID Seeks Biodefense Priority Pathogen Therapeutics
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information regarding efforts to develop therapeutic products that demonstrate activity ...
FDA, HHS Award to Diatherix
DIATHERIX Laboratories, Inc., has been awarded a second federal contract to continue its work in the development of methodologies for ...
Emergent BioSolutions Expands Biodefense Franchise
Emergent BioSolutions today announced that it has acquired the lead broad-spectrum antibiotic candidate, currently receiving Defense Threat Reduction Agency (DTRA) development ...
